EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Retinal Gatekeepers: Molecular Mechanism and Therapeutic Role of Cysteine and Selenocysteine

Eleonora Maceroni iD, Annamaria Cimini iD, Massimiliano Quintiliani, Michele d'Angelo iD, Vanessa Castelli iD

Biomolecules · 2025

DOI: 10.3390/biom15081203 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2025. Verfasst von Eleonora Maceroni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy. Hauptthemen laut MEDLINE: Selenocysteine, Cysteine, Retina, Retinal Degeneration. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 239 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union-NextGenerationEU, Ministry of Enterprises, Centro Europeo Agri-BioSERV.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidative stress is a key contributor to retinal degeneration, as the retina is highly metabolically active and exposed to constant light stimulation. This review explores the crucial roles of cysteine and selenocysteine in redox homeostasis and retinal protection. Cysteine, primarily synthesized via the transsulfuration pathway, is the rate-limiting precursor for glutathione (GSH), the most abundant intracellular antioxidant. Selenocysteine enables the enzymatic activity of selenoproteins, particularly glutathione peroxidases (GPXs), which counteract reactive oxygen species (ROS). Experimental evidence from retinal models confirms that depletion of cysteine or selenocysteine results in impaired antioxidant defense and photoreceptor death. Furthermore, dysregulation of these amino acids contributes to the pathogenesis of age-related macular degeneration (AMD), retinitis pigmentosa (RP), and diabetic retinopathy (DR). Therapeutic approaches including N-acetylcysteine, selenium compounds, and gene therapy targeting thioredoxin systems have demonstrated protective effects in preclinical studies. Targeting cysteine and selenocysteine-dependent systems, as well as modulating the KEAP1–NRF2 pathway, may offer promising strategies for managing retinal neurodegeneration. Advancing our understanding of redox mechanisms and their role in retinal cell viability could unlock new precision treatment strategies for retinal diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SelenocysteineCysteineRetinaRetinal DegenerationHumansAnimalsOxidative StressOxidation-ReductionAntioxidantsReactive Oxygen Species

Stichwörter der Autor:innen

cysteineoxidative stressretinaretinal diseasesselenocysteine

Substanzen

SelenocysteineCysteineAntioxidantsReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.

ORCID-Profile: Eleonora Maceroni, Annamaria Cimini, Michele d'Angelo, Vanessa Castelli

Förderung

  • European Union-NextGenerationEU
  • Ministry of Enterprises
  • Centro Europeo Agri-BioSERV

Zitieren

APA

Maceroni, E., Cimini, A., Quintiliani, M., d'Angelo, M., & Castelli, V. (2025). Retinal Gatekeepers: Molecular Mechanism and Therapeutic Role of Cysteine and Selenocysteine. Biomolecules. https://doi.org/10.3390/biom15081203

Vancouver

Maceroni E, Cimini A, Quintiliani M, d'Angelo M, Castelli V. Retinal Gatekeepers: Molecular Mechanism and Therapeutic Role of Cysteine and Selenocysteine. Biomolecules. 2025. doi:10.3390/biom15081203

BibTeX
@article{Maceroni2025,
  author = {Maceroni, Eleonora and Cimini, Annamaria and Quintiliani, Massimiliano and d'Angelo, Michele and Castelli, Vanessa},
  title = {Retinal Gatekeepers: Molecular Mechanism and Therapeutic Role of Cysteine and Selenocysteine},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15081203}
}
Kostenlos starten →